Shares of Genentech climbed following reports that the biotechnology company was close to a deal to be acquired by Roche Holding for $95 a share.
By DEALBOOK, NY Times: Business
Mon, 03/09/2009 - 12:48pm
Shares of Genentech climbed following reports that the biotechnology company was close to a deal to be acquired by Roche Holding for $95 a share.